Rain Therapeutics Inc. (RAIN) Prices 7.35M Share IPO at $17/Sh

Rain Therapeutics Inc. (NASDAQ: RAIN), a clinical-stage company developing precision oncology therapeutics, today announced the pricing of its initial public offering of 7,352,941 shares of common stock at a public offering price of $17.00 per share. The gross proceeds to Rain from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Rain, are expected to be approximately $125.0 million. All of the shares are being offered by Rain. The shares are expected to begin trading on The Nasdaq Global Select Market on April 23, 2021 under the ticker symbol “RAIN.” In addition, Rain has granted the underwriters a 30-day option to purchase up to an additional 1,102,941 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on April 27, 2021 subject to the satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC, Citigroup, Piper Sandler and Guggenheim Securities, LLC are acting as joint book-running managers for the offering.

The registration statement relating to these securities has been filed with the Securities and Exchange Commission and became effective on April 22, 2021.

You May Also Be Interested In

• Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
• Chinese bubble tea company Chabaidao sees shares tumble in Hong Kong market debut
• Western Alliance Bancorporation (WAL) Appoints Greta Guggenheim, Christopher A. Halmy and Mary Chris Jammet to its Board